Susan Billat

Susan Billat, MBA, currently serves as the Associate Director and Thought Leader Liaison at Alnylam Pharmaceuticals since January 2020. Prior to this role, Susan held the position of Business Account Executive and was a Clinical Science Associate at Saol Therapeutics from 2017 until January 2020. In 2017, Susan also worked as an Acute Care Manager at Takeda. From 2013 to 2016, Susan was the Area Manager for Hospital at CSL Behring. Susan obtained an MBA from California State Polytechnic University-Pomona from 2000 to 2004 and a Bachelor of Science degree from California State University, Fresno.